Results 1 to 10 of about 82,833 (333)

Progressive multifocal leukoencephalopathy

Chinese Journal of Contemporary Neurology and Neurosurgery, 2020
doi：10.3969/j.issn.1672⁃6731.2020.03 ...
Xiao⁃ling YAN
doaj   +2 more sources

Progressive multifocal leukoencephalopathy in rheumatoid arthritis and biological therapies: a case report and review of the literature [PDF]

Journal of Medical Case Reports
Background Progressive multifocal leukoencephalopathy is a rare but potentially fatal disease caused by infection of the central nervous system with John Cunningham polyomavirus.
Barbara Bergmans, Gerwin Roks, Eugène van Puijenbroek, Esther de Vries, Jean-Luc Murk   +4 more
doaj   +2 more sources

JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review

AIDS Research and Therapy, 2020
The human neurotropic virus JC Polyomavirus, a member of the Polyomaviridae family, is the opportunistic infectious agent causing progressive multifocal leukoencephalopathy, typically in immunocompromised individuals.
Vijay Harypursat, Yihong Zhou, Shengquan Tang, Yaokai Chen   +3 more
doaj   +2 more sources

Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab

Emerging Infectious Diseases, 2018
Progressive multifocal leukoencephalopathy (PML) is increasingly being reported in patients undergoing immunotherapy. We report a case of progressive multifocal leukoencephalopathy after treatment with nivolumab, a PD-1 blocker that is used to restore ...
Martin Martinot, Guido Ahle, Inesa Petrosyan, Camille Martinez, Dragos M. Gorun, Mahsa Mohseni-Zadeh, Samira Fafi-Kremer, Martine Tebacher-Alt   +7 more
doaj   +2 more sources

Progressive Multifocal Leukoencephalopathy: Current Insights [PDF]

Degenerative Neurological and Neuromuscular Disease, 2019
Cases of PML should be evaluated according to predisposing factors, as these subgroups differ by incidence rate, clinical course, and prognosis. The three most significant groups at risk of PML are patients with hematological malignancies mostly ...
Auvinen, Eeva, Kartau, Marge, Palomäki, Maarit, Sipilä, Jussi O. T., Verkkoniemi-Ahola, Auli   +4 more
core   +2 more sources

What is the risk of progressive multifocal leukoencephalopathy in patients with ulcerative colitis or Crohn’s Disease treated with vedolizumab? [PDF]

Inflammatory Bowel Diseases, 2018
Background: Progressive multifocal leukoencephalopathy is a serious condition linked to certain diseases and immunosuppressant therapies, including the α4 integrin antagonist natalizumab.
Adang, Amend, Arkema, Berger, Berger, Biogen Idec Inc. Tysabri (Natalizumab) Prescribing information, Biogen Idec Inc. Tysabri (Natalizumab) Summary of Product Characteristics, Bloomgren, Colin, Colombel, Cytel Software Corporation, Dong-Si, Engsig, Fatima Bhayat, Feagan, Fedyk, Huifang Liang, Hunt, Jing Xu, Jovanovic, Khanna, Louis, Major, Mateen, McLean, Milch, Molloy, Pepio, Sandborn, Sands, Soler, Takeda Pharma A/S. ENTYVIO® (vedolizumab) Summary of Product Characteristics, Takeda Pharmaceuticals America Inc. ENTYVIO® (vedolizumab) Prescribing Information, Tan, Timothy Card, Tuccori, Tøttrup, Vermersch, Wollebo   +38 more
core   +3 more sources

A rare case of progressive multifocal leukoencephalopathy [PDF]

Radiology Case Reports
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system (CNS) due to John Cunningham (JC) virus reactivation most often in immunocompromised patients.
Jayanthraj Gone, DO, Tyler Fontaine, DO, Gaurav Kumar, MD   +2 more
doaj   +2 more sources

Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy

Frontiers in Neurology, 2020
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disorder of the brain caused by reactivation of the JC virus (JCV), a polyomavirus that infects at least 60% of the population but is asymptomatic or results in benign symptoms in ...
Peggy S. Eis, Christopher D. Bruno, Todd A. Richmond, Igor J. Koralnik, Barbara A. Hanson, Eugene O. Major, Christina R. Chow, Houria Hendel-Chavez, Bruno Stankoff, Jacques Gasnault, Yassine Taoufik, Eli Hatchwell   +11 more
doaj   +2 more sources

Progressive multifocal leukoencephalopathy in an HIV patient: A case report and literature review [PDF]

Clinical Case Reports, 2023
Key Clinical Message Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection of the brain caused by reactivation of the JC virus, which can lead to a lytic infection of oligodendrocytes.
Ting Lei, Ai Deng, Lianchi Li, Ming Wang, Dongbo Wu, Taoyou Zhou   +5 more
doaj   +2 more sources

Progressive multifocal leukoencephalopathy in a lung transplant recipient [PDF]

Clinical Case Reports
Key Clinical Message Progressive multifocal leukoencephalopathy (PML) is a rare and fatal demyelinating disease of the central nervous system (CNS). The case we describe highlights the importance of considering a diagnosis of PML early (
Jason Sakizadeh, Michael J. Davis, Lauren Fontana   +2 more
doaj   +2 more sources